Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
71
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Rani Therapeutics Holdings Inc - Ordinary Shares Class A market cap is $71.28M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rani Therapeutics Holdings Inc - Ordinary Shares Class A 52 week high is $1.69 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rani Therapeutics Holdings Inc - Ordinary Shares Class A 52 week low is $0.5024 as of November 22, 2026.
Rani Therapeutics Holdings Inc - Ordinary Shares Class A stock price today is $0.5111.
Rani Therapeutics Holdings Inc - Ordinary Shares Class A stock price yesterday was $0.5806.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Rani Therapeutics Holdings Inc - Ordinary Shares Class A's P/E ratio is -2.73.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Rani Therapeutics Holdings Inc - Ordinary Shares Class A P/B ratio is 1.7375.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Rani Therapeutics Holdings Inc - Ordinary Shares Class A 50-day moving average is $0.678.
Rani Therapeutics Holdings Inc - Ordinary Shares Class A has 71 employees.